According to a joint note released by the Ministry of Foreign Affairs and the Ministry of the Environment, Brazil deposited, on the … Biodiversity: Brazil deposits instrument of ratification at the UN and Nagoya Protocol will enter into force in Brazil soon
he Last Tuesday (February 9th, 2021), the Board of the National Health Surveillance Agency (ANVISA) decided not to comment on the Senate … Brazilian National Health Surveillance Agency (ANVISA) decides not to comment on a bill that proposes changes to the Industrial Property Act
The Brazilian Patent and Trademark Office (BPTO) published on Tuesday, January 5th 2021, the first edition of the Manual of Geographical Indications. … BPTO publishes Manual on Geographical Indications
The Brazilian Patent and Trademark Office (BPTO) published, by means of Ordinance n° 404, dated December 21, 2020, phase II of the … BPTO publishes phase II of the Patent Prosecution Highway (PPH) Program
Four years after the publication of the first Examination Guidelines for computer-implemented inventions, the Brazilian Patent Office published a new revised version … New Guidelines for Examination of Patent Applications for Computer-Implemented Inventions
Although it was created in July 2019, the Brazilian Data Protection Office (ANPD) has started to show its operationalization. Two months after … Brazilian Data Protection Office’s website is on
On December 2, 2020, through its Commission on Narcotics, the United Nations approved a recommendation issued by WHO – World Health Organization … UN removes Cannabis from List of Narcotic Substances
The Revised Guidelines for the Examination of Patent Applications in the Biotechnology Field (Normative Instruction INPI/PR n° 118/2020) finally entered into force … Revised Guidelines for the Examination of Patent Applications in the Biotechnology field in force
The Brazilian FDA (ANVISA) published on November 19, 2020, four manuals regarding the analysis of prior consent of patent applications related to … ANVISA published manuals related to prior consent of patent applications
On November 17th, 2020, ANVISA’s Board of Directors (BoD) unanimously granted an administrative appeal for reassessment of prior consent of a patent … ANVISA decides that a patent application related to pharmaceutical use of cannabinoids is not to be deemed as against public health
